HDAC1 Polyclonal antibody (10197-1-AP)

EC:3.5.1.-; EC:3.5.1.98; GON 10; HD1; histone deacetylase 1

反应种属:Human, Mouse, Rat
抗原名称:HDAC1
应用:WB, IHC, ELISA, IF/ICC, IP
标记:Unconjugated

用户验证的应用

经验证应用

项目详情
Positive WB detected inC6 cells, HeLa cells, mouse testis tissue, Jurkat cells, K-562 cells, NIH/3T3 cells
Positive IP detected inHeLa cells
Positive IHC detected inmouse colon tissue, human testis tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF/ICC detected inHeLa cells

推荐稀释说明

It is recommended that this reagent should be titrated in each testing system to obtain optimal results. Sample-dependent, Check data in validation data gallery.

详细信息

免疫原CatNo: Ag0256 Product name: Recombinant human HDAC1 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 184-482 aa of BC000301 Sequence: EEAFYTTDRVMTVSFHKYGEYFPGTGDLRDIGAGKGKYYAVNYPLRDGIDDESYEAIFKPVMSKVMEMFQPSAVVLQCGSDSLSGDRLGCFNLTIKGHAKCVEFVKSFNLPMLMLGGGGYTIRNVARCWTYETAVALDTEIPNELPYNDYFEYFGPDFKLHISPSNMTNQNTNEYLEKIKQRLFENLRMLPHAPGVQMQAIPEDAIPEESGDEDEDDPDKRISICSSDKRIACEEEFSDSEEEGEGGRKNSSNFKKAKRVKTEDEKEKDPEEKKEVTEEEKTKEEKPEAKGVKEEVKLA
宿主/亚型Rabbit / IgG
抗体类型Polyclonal
产品类型Antibody
产品形式Liquid
偶联物Unconjugated
纯化方式Antigen affinity purification
储存缓冲液PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
储存条件Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20 o C storage.
RRIDAB_2118062
UniProt IDQ13547
Gene ID3065

背景信息

Background Histone Deacetylase 1 (HDAC1) is a nuclear localized class I histone deacetylase that plays a role in the regulation of gene expression, mainly by repression of gene activity. Additionally, HDAC can mediate deacetylation of a subset of non-histone proteins, leading to their degradation. HDAC1 activity has an impact on cell growth, proliferation, and death. 1. What is the molecular weight of HDAC1? The molecular size of HDAC1 is 60 kDa. 2. What is the subcellular localization of HDAC1? Unlike some HDACs, HDAC1 is present entirely in the nucleus. Our HDAC1 antibody has been broadly tested for IF/ICC. 3. I cannot detect an HDAC1 specific signal in my sample during western blotting. Make sure that you efficiently extract nuclear proteins during your sample preparation. Some lysis buffers (e.g., based on Triton X-100) may not extract nuclear proteins. We recommend using RIPA buffer ( https://www.ptglab.com/support/protocols/ ). We highly recommend using nuclear loading control antibodies, such as lamin B1 or PCNA ( https://www.ptglab.com/news/blog/loading-control-antibodies-for-western-blotting/ ). Alternatively, you may consider performing cell fractionation. 4. How do I perform chromatin immunoprecipitation (ChiP) with the HDAC1 antibody? We recommend using our standard chromatin immunoprecipitation protocol ( https://www.ptglab.com/media/2708/web_chip-protocol.pdf ). 5. Is HDAC1 post-translationally modified? HDAC1 is a protein deacetylase but itself can also be a subject of post-translational modifications, including phosphorylation, acetylation, ubiquitination, SUMOylation, nitrosylation, and carbonylation (PMID: 21197454). 6. What is the role of HDAC1 in cancer? The acetylation and deacetylation of histones play an important part in the epigenetic regulation of gene expression. Alterations in the balance between these two opposing processes changes chromosome remodeling and increased deacetylation leads to gene silencing. HDAC1 levels are increased in many cancer cell types and the role of HDAC1 in cancer is connected not only to histone deacetylation but also to the deacetylation of other proteins, such as Rb family proteins, estrogen receptors, and p53 protein (PMID: 19383284).

文献引用 (60)

The dual HDAC/PI3K inhibitor CUDC-907 inhibits the growth and proliferation of MYC-driven Group 3 medulloblastoma

双重 HDAC/PI3K 抑制剂 CUDC-907 可抑制 MYC 驱动的 3 组髓母细胞瘤的生长和增殖。

Pan Gou,Chencheng Fang,Man Xu,Dandan Zhang,Xuanxuan Wu,Li Zhang,Xiao Li,Man Li,Lu Gan,Jinjin Luo,Hongjuan Cui,Ping Liang

GMPS inhibits the proliferation and migration of non-small cell lung cancer via the regulation of the DNMT 1/SERPINB2 axis.

GMPS 通过调节 DNMT 1/SERPINB2 轴抑制非小细胞肺癌的增殖和迁移

Guo Tingting, Liu Lei, Zeng Lingyan, Yang Ying, Song Tingting, Zhao Huachang, Qiu Zhixin

IFI16 recruits HDAC1 and HDAC2 to deacetylate the Kaposi's sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen (LANA), facilitating latency.

IFI16 招募 HDAC1 和 HDAC2 来使卡波西肉瘤相关疱疹病毒 (KSHV) 潜伏相关核抗原 (LANA) 去乙酰化,从而促进潜伏

Ghosh Anandita, Britto Jeffrey, Chandran Bala, Roy Arunava

IFI16 Mediates Deacetylation of KSHV Chromatin via Interaction with NuRD and Sin3A Co-Repressor Complexes.

IFI16 通过与 NuRD 和 Sin3A 共抑制复合物相互作用介导 KSHV 染色质的去乙酰化

Ghosh Anandita, Chandran Bala, Roy Arunava

Prognostic and immunotherapeutic response prediction in hepatocellular carcinoma: role of non-histone acetylation/deacetylation scoring.

肝细胞癌的预后和免疫治疗反应预测:非组蛋白乙酰化/去乙酰化评分的作用

Li Jizhen, Huang Sisi, Yuan Fangling, Yang Xunjun, Xie Qipeng

TEC-mediated tRF-31R9J regulates histone lactylation and acetylation by HDAC1 to suppress hepatocyte ferroptosis and improve non-alcoholic steatohepatitis

TEC介导的tRF-31R9J调控HDAC1组蛋白乳酸化和乙酰化抑制肝细胞铁死亡、改善非酒精性脂肪性肝炎

Juanjuan Zhu, Xian Wu, Mao Mu, Quan Zhang, Xueke Zhao

Atf3-mediated metabolic reprogramming in hepatic macrophage orchestrates metabolic dysfunction-associated steatohepatitis

肝巨噬细胞中 Atf3 介导的代谢重编程引发代谢功能障碍相关的脂肪性肝炎

Shuwei Hu, Rui Li, Dongxu Gong, Pei Hu, Jitu Xu, Yingjie Ai, Xiaojie Zhao, Chencheng Hu, Minghuan Xu, Chenxi Liu, Shuyu Chen, Jie Fan, Zhonghua Zhao, Zhigang Zhang, Huijuan Wu, Yanyong Xu

TRIP13 regulates progression of gastric cancer through stabilising the expression of DDX21

TRIP13 通过稳定 DDX21 的表达来调控胃癌的进展

Guanghui Zhang, Rui Yang, Baiyan Wang, Qiujin Yan, Peiyuan Zhao, Jiaming Zhang, Weiyu Su, Lianhe Yang, Hongjuan Cui

PRMT1 promotes epigenetic reprogramming associated with acquired chemoresistance in pancreatic cancer

PRMT1 促进与胰腺癌获得性化疗耐药相关的表观遗传重编程

Chan D K Nguyen, Benjamín A Colón-Emeric, Shigekazu Murakami, Mia N Y Shujath, Chunling Yi

Multi-omics characterization of esophageal squamous cell carcinoma identifies molecular subtypes and therapeutic targets

食管鳞状细胞癌的多组学表征可确定分子亚型和治疗靶点

Dengyun Zhao, Yaping Guo, Huifang Wei, Xuechao Jia, Yafei Zhi, Guiliang He, Wenna Nie, Limeng Huang, Penglei Wang, Kyle Vaughn Laster, Zhicai Liu, Jinwu Wang, Mee-Hyun Lee, Zigang Dong, Kangdong Liu
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6